PT  - JOURNAL ARTICLE
AU  - Kinnunen, K
AU  - Puustjärvi, T
AU  - Teräsvirta, M
AU  - Nurmenniemi, P
AU  - Heikura, T
AU  - Laidinen, S
AU  - Paavonen, T
AU  - Uusitalo, H
AU  - Ylä-Herttuala, S
TI  - Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes
AID  - 10.1136/bjo.2008.148841
DP  - 2009 Aug 01
TA  - British Journal of Ophthalmology
PG  - 1109--1115
VI  - 93
IP  - 8
4099  - http://bjo.bmj.com/content/93/8/1109.short
4100  - http://bjo.bmj.com/content/93/8/1109.full
SO  - Br J Ophthalmol2009 Aug 01; 93
AB  - Aims: The aim of the study was to evaluate the histopathology of neovascular tufts and vitreous samples collected from patients with diabetes.Methods: Vitreous samples and neovascular tufts were collected from patients with type 1 (n = 13) and (n = 17) type 2 diabetes with proliferative retinopathy, and from controls with a macular hole (n = 5). Neovessels were analysed using immunohistochemistry and vitreous samples with an enzyme-linked immunosorbent assay (ELISA). The main outcome measure was to examine differences in the levels of growth factors in patients with type 1 and type 2 diabetes with proliferative retinopathy.Results: Vascular endothelial growth factor (VEGF)-A was most strongly present in the samples from patients with type 1 diabetes. In type 2 diabetes, VEGF-D was more abundantly present than in type 1 diabetes. Angiopoietin (ANG)-2 was also abundantly present. Macrophages and nuclear factor kappa B (NFκB) were found, indicating the presence of an inflammatory process in the neovascular tissues.Conclusions: VEGF-A and ANG-2 are equally important in the neovascular process in both type 1 and type 2 diabetes. VEGF-D is abundantly present in type 2 diabetes. In order to achieve better control of diabetic retinopathy, it might be beneficial to develop treatments that prevent the actions of ANG-2 and VEGF-D.